Skip to main content
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1986 Apr;62(726):269–272. doi: 10.1136/pgmj.62.726.269

Male fertility in Crohn's disease.

D Burnell, J Mayberry, B J Calcraft, J S Morris, J Rhodes
PMCID: PMC2418652  PMID: 2872665

Abstract

The fertility of 70 men with Crohn's disease and a group of age matched controls were compared. Crohn's disease was associated with a significant reduction in family size independent of steroid or sulphasalazine treatment.

Full text

PDF
269

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Birnie G. G., McLeod T. I., Watkinson G. Incidence of sulphasalazine-induced male infertility. Gut. 1981 Jun;22(6):452–455. doi: 10.1136/gut.22.6.452. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Freeman J. G., Reece V. A., Venables C. W. Sulphasalazine and spermatogenesis. Digestion. 1982;23(1):68–71. doi: 10.1159/000198712. [DOI] [PubMed] [Google Scholar]
  3. O'Moráin C., Smethurst P., Doré C. J., Levi A. J. Reversible male infertility due to sulphasalazine: studies in man and rat. Gut. 1984 Oct;25(10):1078–1084. doi: 10.1136/gut.25.10.1078. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Summers R. W., Switz D. M., Sessions J. T., Jr, Becktel J. M., Best W. R., Kern F., Jr, Singleton J. W. National Cooperative Crohn's Disease Study: results of drug treatment. Gastroenterology. 1979 Oct;77(4 Pt 2):847–869. [PubMed] [Google Scholar]
  5. Toovey S., Hudson E., Hendry W. F., Levi A. J. Sulphasalazine and male infertility: reversibility and possible mechanism. Gut. 1981 Jun;22(6):445–451. doi: 10.1136/gut.22.6.445. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Toth A. Reversible toxic effect of salicylazosulfapyridine on semen quality. Fertil Steril. 1979 May;31(5):538–540. doi: 10.1016/s0015-0282(16)44000-8. [DOI] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES